Pulmonx beats third-quarter revenue estimates and sets full-year outlook
Pulmonx reported third-quarter revenue of $22.835 million against an IBES estimate of $21.9 million, and gave a full-year revenue outlook.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to Reuters, Pulmonx reported third-quarter revenue of $22.835 million, above the IBES estimate of $21.9 million. Gross profit came in at $17.399 million, net loss at $8.394 million, and operating loss at $7.49 million.
For the full fiscal year, Pulmonx guided revenue to $90-92 million, slightly below the IBES estimate of $90.6 million but close to it.
why it matters
For markets this is a results report from a small medical-device company: revenue topped consensus, yet the loss remains significant. It matters mainly to investors in Pulmonx shares and to participants in the medical-device sector.
tags
instruments
sources
- BRIEF-Pulmonx Q3 EPS USD -0.19 — Reuters, 27 October 2026 at 20:06 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗